Body mass index and long-term risk of death from esophageal squamous cell carcinoma in a Chinese population

Thoracic Cancer

Volumn 7, Issue 4, 2016, Pages 387-392

  Wang, Shao Ming ^a   Fan, Jin Hu ^a   Jia, Meng Meng ^a   Yang, Zhao ^a   Zhang, Yu Qing ^a   Qiao, You Lin ^a   Taylor, Philip R ^b  

^a CANCER HOSPITAL   (China)

^b NATIONAL CANCER INSTITUTE   (United States)

Author keywords

Body mass index (BMI); Chinese population; esophageal squamous cell carcinoma (ESCC); overweight; underweight

Indexed keywords

ADULT; AGED; ALCOHOL CONSUMPTION; ARTICLE; BODY MASS; CANCER INCIDENCE; CANCER MORTALITY; CANCER RISK; CHINESE; CLASSIFICATION; CONTROLLED STUDY; CUMULATIVE EVENT RATE; DISEASE ASSOCIATION; EPIDEMIOLOGICAL DATA; ESOPHAGEAL SQUAMOUS CELL CARCINOMA; FEMALE; FOLLOW UP; HUMAN; LONG TERM RISK; MAJOR CLINICAL STUDY; MALE; OBESITY; PRIORITY JOURNAL; PROSPECTIVE STUDY; RISK; RISK REDUCTION; SEX DIFFERENCE; SMOKING; UNDERWEIGHT;

EID: 84990191613     PISSN: 17597706     EISSN: 17597714     Source Type: Journal    
DOI: 10.1111/1759-7714.12340     Document Type: Article

References (22)

1. Ferlay J, Soerjomataram I, Ervik M, et al. GLOBOCAN 2012 v1.0, Cancer Incidence and Mortality Worldwide: IARC CancerBase No. 11 [Internet]. Lyon, France: International Agency for Research on Cancer; 2013. [Cited 25 Dec 2015.] Available from URL: http://globocan.iarc.fr
2. Flegal KM, Kit BK, Orpana H, Graubard BI. Association of all-cause mortality with overweight and obesity using standard body mass index categories: A systematic review and meta-analysis. JAMA 2013; 309: 71–82.
3. Gu D, He J, Duan X et al. Body weight and mortality among men and women in China. JAMA 2006; 295: 776–783.
4. Cook MB, Freedman ND, Gamborg M, Sorensen TI, Baker JL. Childhood body mass index in relation to future risk of oesophageal adenocarcinoma. Br J Cancer 2015; 112: 601–607.
5. Hoyo C, Cook MB, Kamangar F et al. Body mass index in relation to oesophageal and oesophagogastric junction adenocarcinomas: A pooled analysis from the International BEACON Consortium. Int J Epidemiol 2012; 41: 1706–1718.
6. Löfdahl HE, Lane A, Lu Y et al. Increased population prevalence of reflux and obesity in the United Kingdom compared with Sweden: A potential explanation for the difference in incidence of esophageal adenocarcinoma. Eur J Gastroenterol Hepatol 2011; 23: 128–132.
7. O'Doherty MG, Freedman ND, Hollenbeck AR, Schatzkin A, Abnet CC. A prospective cohort study of obesity and risk of oesophageal and gastric adenocarcinoma in the NIH-AARP Diet and Health Study. Gut 2012; 61: 1261–1268.
8. Kendall BJ, Wilson LF, Olsen CM et al. Cancers in Australia in 2010 attributable to overweight and obesity. Aust N Z J Public Health 2015; 39: 452–457.
9. Lahmann PH, Pandeya N, Webb PM, Green AC, Whiteman DC, Australian Cancer Study. Body mass index, long-term weight change, and esophageal squamous cell carcinoma: Is the inverse association modified by smoking status? Cancer 2012; 118: 1901–1909.
10. Tran GD, Sun XD, Abnet CC et al. Prospective study of risk factors for esophageal and gastric cancers in the Linxian general population trial cohort in China. Int J Cancer 2005; 113: 456–463.
11. Smith M, Zhou M, Whitlock G et al. Esophageal cancer and body mass index: Results from a prospective study of 220 000 men in China and a meta-analysis of published studies. Int J Cancer 2008; 122: 1604–1610.
12. Fahey PP, Mallitt KA, Astell-Burt T, Stone G, Whiteman DC. Impact of pre-diagnosis behavior on risk of death from esophageal cancer: A systematic review and meta-analysis. Cancer Causes Control 2015; 26: 1365–1373.
13. Clinical guidelines on the identification, evaluation, and treatment of overweight and obesity in adults: Executive summary. Expert panel on the identification, evaluation, and treatment of overweight in adults. Am J Clin Nutr 1998; 68: 899–917.
14. China NHaFPCotPsRo. Criteria of weight for adults. File No WS/T 428–2013 2013.
15. Qiao YL, Dawsey SM, Kamangar F et al. Total and cancer mortality after supplementation with vitamins and minerals: Follow-up of the Linxian General Population Nutrition Intervention Trial. (Published erratum appears in J Natl Cancer Inst 2010; 102: 140) J Natl Cancer Inst 2009; 101: 507–518.
16. Li JY, Taylor PR, Li B et al. Nutrition intervention trials in Linxian, China: Multiple vitamin/mineral supplementation, cancer incidence, and disease-specific mortality among adults with esophageal dysplasia. J Natl Cancer Inst 1993; 85: 1492–1498.
17. Li B, Taylor PR, Li JY et al. Linxian nutrition intervention trials. Design, methods, participant characteristics, and compliance. Ann Epidemiol 1993; 3: 577–585.
18. Blot WJ, Li JY, Taylor PR, Guo W, Dawsey SM, Li B. The Linxian trials: Mortality rates by vitamin-mineral intervention group. Am J Clin Nutr 1995; 62 (6 Suppl): 1424S–1426.
19. Engeland A, Tretli S, Bjorge T. Height and body mass index in relation to esophageal cancer; 23-year follow-up of two million Norwegian men and women. Cancer Causes Control 2004; 15: 837–843.
20. Mark SD, Qiao YL, Dawsey SM et al. Prospective study of serum selenium levels and incident esophageal and gastric cancers. J Natl Cancer Inst 2000; 92: 1753–1763.
21. Taylor PR, Qiao YL, Abnet CC et al. Prospective study of serum vitamin E levels and esophageal and gastric cancers. J Natl Cancer Inst 2003; 95: 1414–1416.
22. Steffen A, Schulze MB, Pischon T et al. Anthropometry and esophageal cancer risk in the European prospective investigation into cancer and nutrition. Cancer Epidemiol Biomarkers Prev 2009; 18: 2079–2089.